关注
Alexander colevas
Alexander colevas
Professor of Medicine, Stanford University
在 stanford.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Nivolumab for recurrent squamous-cell carcinoma of the head and neck
RL Ferris, G Blumenschein Jr, J Fayette, J Guigay, AD Colevas, L Licitra, ...
New England Journal of Medicine 375 (19), 1856-1867, 2016
46322016
CTCAE v3. 0: development of a comprehensive grading system for the adverse effects of cancer treatment
A Trotti, AD Colevas, A Setser, V Rusch, D Jaques, V Budach, C Langer, ...
Seminars in radiation oncology 13 (3), 176-181, 2003
31422003
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
MR Posner, DM Hershock, CR Blajman, E Mickiewicz, E Winquist, ...
New England Journal of Medicine 357 (17), 1705-1715, 2007
20692007
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
ML Gillison, AM Trotti, J Harris, A Eisbruch, PM Harari, DJ Adelstein, ...
The Lancet 393 (10166), 40-50, 2019
11442019
Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology
DG Pfister, S Spencer, D Adelstein, D Adkins, Y Anzai, DM Brizel, ...
Journal of the National Comprehensive Cancer Network 18 (7), 873-898, 2020
8232020
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by …
RL Ferris, G Blumenschein Jr, J Fayette, J Guigay, AD Colevas, L Licitra, ...
Oral oncology 81, 45-51, 2018
7492018
NCCN guidelines insights: head and neck cancers, version 1.2018
AD Colevas, SS Yom, DG Pfister, S Spencer, D Adelstein, D Adkins, ...
Journal of the National Comprehensive Cancer Network 16 (5), 479-490, 2018
5642018
Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia
JC Byrd, TS Lin, JT Dalton, D Wu, MA Phelps, B Fischer, M Moran, ...
Blood 109 (2), 399-404, 2007
4642007
E1308: phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of …
S Marur, S Li, AJ Cmelak, ML Gillison, WJ Zhao, RL Ferris, WH Westra, ...
Journal of Clinical Oncology 35 (5), 490, 2017
4612017
First-in-human, first-in-class phase I trial of the anti-CD47 antibody Hu5F9-G4 in patients with advanced cancers
BI Sikic, N Lakhani, A Patnaik, SA Shah, SR Chandana, D Rasco, ...
Journal of Clinical Oncology 37 (12), 946, 2019
4492019
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related …
KJ Harrington, RL Ferris, G Blumenschein, AD Colevas, J Fayette, ...
The Lancet Oncology 18 (8), 1104-1115, 2017
4032017
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial
NY Lee, Q Zhang, DG Pfister, J Kim, AS Garden, J Mechalakos, K Hu, ...
The lancet oncology 13 (2), 172-180, 2012
3772012
Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma
LB Nabors, T Mikkelsen, SS Rosenfeld, F Hochberg, NS Akella, JD Fisher, ...
Journal of Clinical Oncology 25 (13), 1651-1657, 2007
3742007
Patient-reported outcomes and the evolution of adverse event reporting in oncology
A Trotti, AD Colevas, A Setser, E Basch
Journal of Clinical Oncology 25 (32), 5121-5127, 2007
3672007
NCCN guidelines insights: head and neck cancers, version 2.2017
D Adelstein, ML Gillison, DG Pfister, S Spencer, D Adkins, DM Brizel, ...
Journal of the National Comprehensive Cancer Network 15 (6), 761-770, 2017
3472017
Inhibition of poly (ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models
JM Albert, C Cao, KW Kim, CD Willey, L Geng, D Xiao, H Wang, A Sandler, ...
Clinical cancer research 13 (10), 3033-3042, 2007
3312007
Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck
AD Colevas
Journal of Clinical Oncology 24 (17), 2644-2652, 2006
3172006
Ameloblastoma: a clinical review and trends in management
AC McClary, RB West, AC McClary, JR Pollack, NJ Fischbein, ...
European Archives of Oto-Rhino-Laryngology 273, 1649-1661, 2016
3052016
Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity‐modulated radiotherapy
JJ Pan, WT Ng, JF Zong, LLK Chan, B O'Sullivan, SJ Lin, HCK Sze, ...
Cancer 122 (4), 546-558, 2016
3052016
Head and neck cancers, version 2.2014
DG Pfister, S Spencer, DM Brizel, B Burtness, PM Busse, JJ Caudell, ...
Journal of the National Comprehensive Cancer Network 12 (10), 1454-1487, 2014
3042014
系统目前无法执行此操作,请稍后再试。
文章 1–20